Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of NK Cell Therapy
1.2 Key Market Segments
1.2.1 NK Cell Therapy Segment by Type
1.2.2 NK Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NK Cell Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global NK Cell Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global NK Cell Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NK Cell Therapy Market Competitive Landscape
3.1 Global NK Cell Therapy Sales by Manufacturers (2019-2024)
3.2 Global NK Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global NK Cell Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers NK Cell Therapy Sales Sites, Area Served, Product Type
3.6 NK Cell Therapy Market Competitive Situation and Trends
3.6.1 NK Cell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest NK Cell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NK Cell Therapy Industry Chain Analysis
4.1 NK Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of NK Cell Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NK Cell Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NK Cell Therapy Sales Market Share by Type (2019-2024)
6.3 Global NK Cell Therapy Market Size Market Share by Type (2019-2024)
6.4 Global NK Cell Therapy Price by Type (2019-2024)
7 NK Cell Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NK Cell Therapy Market Sales by Application (2019-2024)
7.3 Global NK Cell Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global NK Cell Therapy Sales Growth Rate by Application (2019-2024)
8 NK Cell Therapy Market Segmentation by Region
8.1 Global NK Cell Therapy Sales by Region
8.1.1 Global NK Cell Therapy Sales by Region
8.1.2 Global NK Cell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America NK Cell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe NK Cell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific NK Cell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America NK Cell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa NK Cell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Nektar Therapeutics
9.1.1 Nektar Therapeutics NK Cell Therapy Basic Information
9.1.2 Nektar Therapeutics NK Cell Therapy Product Overview
9.1.3 Nektar Therapeutics NK Cell Therapy Product Market Performance
9.1.4 Nektar Therapeutics Business Overview
9.1.5 Nektar Therapeutics NK Cell Therapy SWOT Analysis
9.1.6 Nektar Therapeutics Recent Developments
9.2 Innate Pharma SA
9.2.1 Innate Pharma SA NK Cell Therapy Basic Information
9.2.2 Innate Pharma SA NK Cell Therapy Product Overview
9.2.3 Innate Pharma SA NK Cell Therapy Product Market Performance
9.2.4 Innate Pharma SA Business Overview
9.2.5 Innate Pharma SA NK Cell Therapy SWOT Analysis
9.2.6 Innate Pharma SA Recent Developments
9.3 Affimed
9.3.1 Affimed NK Cell Therapy Basic Information
9.3.2 Affimed NK Cell Therapy Product Overview
9.3.3 Affimed NK Cell Therapy Product Market Performance
9.3.4 Affimed NK Cell Therapy SWOT Analysis
9.3.5 Affimed Business Overview
9.3.6 Affimed Recent Developments
9.4 Chipscreen Biosciences
9.4.1 Chipscreen Biosciences NK Cell Therapy Basic Information
9.4.2 Chipscreen Biosciences NK Cell Therapy Product Overview
9.4.3 Chipscreen Biosciences NK Cell Therapy Product Market Performance
9.4.4 Chipscreen Biosciences Business Overview
9.4.5 Chipscreen Biosciences Recent Developments
9.5 Fate Therapeutics
9.5.1 Fate Therapeutics NK Cell Therapy Basic Information
9.5.2 Fate Therapeutics NK Cell Therapy Product Overview
9.5.3 Fate Therapeutics NK Cell Therapy Product Market Performance
9.5.4 Fate Therapeutics Business Overview
9.5.5 Fate Therapeutics Recent Developments
9.6 Glycostem Therapeutics
9.6.1 Glycostem Therapeutics NK Cell Therapy Basic Information
9.6.2 Glycostem Therapeutics NK Cell Therapy Product Overview
9.6.3 Glycostem Therapeutics NK Cell Therapy Product Market Performance
9.6.4 Glycostem Therapeutics Business Overview
9.6.5 Glycostem Therapeutics Recent Developments
9.7 Dragonfly Therapeutics
9.7.1 Dragonfly Therapeutics NK Cell Therapy Basic Information
9.7.2 Dragonfly Therapeutics NK Cell Therapy Product Overview
9.7.3 Dragonfly Therapeutics NK Cell Therapy Product Market Performance
9.7.4 Dragonfly Therapeutics Business Overview
9.7.5 Dragonfly Therapeutics Recent Developments
9.8 Kiadis Pharma
9.8.1 Kiadis Pharma NK Cell Therapy Basic Information
9.8.2 Kiadis Pharma NK Cell Therapy Product Overview
9.8.3 Kiadis Pharma NK Cell Therapy Product Market Performance
9.8.4 Kiadis Pharma Business Overview
9.8.5 Kiadis Pharma Recent Developments
9.9 NantWorks
9.9.1 NantWorks NK Cell Therapy Basic Information
9.9.2 NantWorks NK Cell Therapy Product Overview
9.9.3 NantWorks NK Cell Therapy Product Market Performance
9.9.4 NantWorks Business Overview
9.9.5 NantWorks Recent Developments
9.10 Nkarta Therapeutics
9.10.1 Nkarta Therapeutics NK Cell Therapy Basic Information
9.10.2 Nkarta Therapeutics NK Cell Therapy Product Overview
9.10.3 Nkarta Therapeutics NK Cell Therapy Product Market Performance
9.10.4 Nkarta Therapeutics Business Overview
9.10.5 Nkarta Therapeutics Recent Developments
9.11 Fortress Biotech
9.11.1 Fortress Biotech NK Cell Therapy Basic Information
9.11.2 Fortress Biotech NK Cell Therapy Product Overview
9.11.3 Fortress Biotech NK Cell Therapy Product Market Performance
9.11.4 Fortress Biotech Business Overview
9.11.5 Fortress Biotech Recent Developments
10 NK Cell Therapy Market Forecast by Region
10.1 Global NK Cell Therapy Market Size Forecast
10.2 Global NK Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe NK Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific NK Cell Therapy Market Size Forecast by Region
10.2.4 South America NK Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of NK Cell Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global NK Cell Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of NK Cell Therapy by Type (2025-2030)
11.1.2 Global NK Cell Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of NK Cell Therapy by Type (2025-2030)
11.2 Global NK Cell Therapy Market Forecast by Application (2025-2030)
11.2.1 Global NK Cell Therapy Sales (K Units) Forecast by Application
11.2.2 Global NK Cell Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
